Federal health officials will no longer routinely approve annual COVID-19 shots for younger adults and children who are ...

The 2025 "American Idol" champion stops by "GMA" to perform his new single, “Heal,” and reflect on his path to victory. A new Trump administration vaccine policy will limit access to COVID-19 shots.

Novavax makes the nation’s only traditional protein-based coronavirus vaccine – and until now it had emergency authorization ...

Previously granted Emergency Use Authorization, Nuvaxovid is now available for individuals over 12 years of age.

The FDA plans to require new clinical trials for approval of annual COVID-19 boosters for healthy Americans under 65.

The US Food and Drug Administration is changing the way it approves Covid-19 vaccines for Americans, a move that may limit ...

In the NEJM article, the FDA notes that covid booster uptake has been low in the US, with less than a quarter of people ...

"The FDA will approve vaccines for high-risk persons and, at the same time, demand robust, gold-standard data on persons at ...

The FDA has approved Nuvaxovid to prevent COVID-19 in adults 65 years and older and high-risk individuals 12 through 64 years.

The new framework was well-received by biopharma analysts, who say it “largely formalizes” current COVID-19 vaccination ...

The agency will narrow its approval for updated coronavirus vaccines, marking a significant shift in the agency’s approach to ...